Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00074334
What this trial is testing

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 3
Not applicableStudy completedNCT00802061
What this trial is testing

Sleep at 30 Degrees in Glaucoma

Who this might be right for
Glaucoma
University Health Network, Toronto
Early research (Phase 1)Ended earlyNCT03927573
What this trial is testing

Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker

Who this might be right for
Non-small Cell Lung CancerProstate CancerRenal Cancer+1 more
AvenCell Europe GmbH 23
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Post-approval studies (Phase 4)Study completedNCT00028262
What this trial is testing

Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis

Who this might be right for
Infantile Neronal Ceroid Lipofuscinosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 10
Testing effectiveness (Phase 2)Ended earlyNCT04544007
What this trial is testing

A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

Who this might be right for
NF1Low-grade Glioma
University of Alabama at Birmingham 3
Post-approval studies (Phase 4)Study completedNCT04792567
What this trial is testing

Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)

Who this might be right for
Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals 41
Large-scale testing (Phase 3)Study completedNCT04353492
What this trial is testing

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 562
Not applicableStudy completedNCT03562975
What this trial is testing

Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus

Who this might be right for
Multiple SclerosisPathologic ProcessesDemyelinating Diseases+5 more
University of South Florida 18
Not applicableActive Not RecruitingNCT06563700
What this trial is testing

Novel Lenses for Myopia Progression Trial

Who this might be right for
Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center 342
Early research (Phase 1)UnknownNCT01226407
What this trial is testing

Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile

Who this might be right for
Solid Tumour
CrystalGenomics, Inc. 36
Not applicableNot Yet RecruitingNCT07542691
What this trial is testing

Respiratory Physiotherapy and PMR After Cardiac Surgery

Who this might be right for
Cardiac SurgeryDyspneaAnxiety+1 more
Istanbul Aydın University 116
Testing effectiveness (Phase 2)UnknownNCT02132988
What this trial is testing

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Mackay Memorial Hospital 110
Testing effectiveness (Phase 2)WithdrawnNCT01479179
What this trial is testing

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01887288
What this trial is testing

Capecitabine With Digoxin for Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Western Regional Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT01910259
What this trial is testing

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Who this might be right for
Secondary Progressive Multiple Sclerosis
University College, London 445
Testing effectiveness (Phase 2)Ended earlyNCT03531827
What this trial is testing

Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Who this might be right for
Metastatic Castration Resistant Prostate CancerProstate Neoplasms
National Cancer Institute (NCI) 4
Very early researchEnded earlyNCT03927274
What this trial is testing

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Who this might be right for
Glioma of Brain
H. Lee Moffitt Cancer Center and Research Institute 3
Not applicableStudy completedNCT05697380
What this trial is testing

CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)

Who this might be right for
AphasiaPrimary Progressive AphasiaDementia+2 more
University of Chicago 8
Early research (Phase 1)Looking for participantsNCT07652762
What this trial is testing

IN10018 in Combination With Dalpiciclib for Progressive Meningiomas

Who this might be right for
MeningiomaCDK4/6 Inhibitor
Capital Medical University 24
Next Page